- April 13, 2017
The purpose of this study is to evaluate the safety and effectiveness of an investigational medication for fibromyalgia as compared to a placebo.
Duration: Approximately 12 weeks
Number of visits to CKRA: 7
Compensation: Up to $525 for time and travel
NOTE: Qualified participants must be between the ages of 18 and 80 years old, have had fibromyalgia for at least the past 3 months, and must not have any other disorders that would otherwise explain the pain. Other criteria also apply.